Bioness, Valencia, California, received the Frost & Sullivan 2015 North American Market Leadership Award in Functional Electrical Stimulation (FES) for Walking as part of the Excellence in Best Practices Awards, at a gala held July 17 in Boston. The company was recognized for driving significant value in three primary areas: improved electrodes that increase repeatability and reduce setup time, adaptable gait detection technology delivered via proprietary algorithms, and expanding availability outside the rehabilitation setting to individuals in the community who are limited by paralysis of the lower-limbs.
Bioness’ lower-limb FES products are used to treat patients experiencing gait disturbances due to central nervous system pathologies including stroke, multiple sclerosis, spinal cord injury, traumatic brain injury and cerebral palsy. According to the Frost & Sullivan report, “Bioness strives to help those suffering from lower extremity paralysis gain ‘mobility, confidence, and independence…. Bioness has achieved a leadership position with a market share over 75%.”
Frost & Sullivan works with companies to develop market growth strategies. Its Best Practices Awards recognize companies throughout a range of regional and global markets for superior leadership, technological innovation, customer service, and strategic product development. Frost & Sullivan’s industry analyst team benchmarks market participants and measures their performance through independent, primary interviews, and secondary industry research in order to evaluate and identify best practices.
